Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · Sign up for real-time

Updates arrive automatically.

  • Jeep® Brand Takes Adventure to Marvel Studios' 'Avengers: Doomsday' Universe in Epic Finale of Sweeping Yearlong Global Collaboration
    PR·

    Jeep® Brand Takes Adventure to Marvel Studios' 'Avengers: Doomsday' Universe in Epic Finale of Sweeping Yearlong Global Collaboration

    "A Jeep® 4x4 for Any Universe" campaign serves as the third and final chapter in the yearlong Jeep brand and Marvel collaboration, taking legendary-adventure Jeep vehicles and iconic characters across the worlds of Marvel Studios' "Avengers: Doomsday," which hits theaters December 18The cobranded spot takes audiences from the Avengers Tower in New York to the X-Mansion, and from the Fantastic Four Universe to Latveria, transforming Marvel worlds into an imaginative showcase for Jeep brand adventure and legendary 4x4 capability, showcasing how Jeep vehicles show up as reliable in any universeCampaign features fan-fav

    $STLA
  • CIBC Global Asset Management recognized for investment excellence at the 2026 LSEG Lipper Fund Awards
    PR·

    CIBC Global Asset Management recognized for investment excellence at the 2026 LSEG Lipper Fund Awards

    CIBC Global Asset Management™ (CIBC GAM) today announced it received four awards at the 2026 Canada LSEG Lipper Fund Awards, reflecting the firm's commitment to delivering innovative, high-quality investment solutions to Canadian investors. "We're honoured to be recognized for delivering investment solutions that help clients achieve their goals with confidence," said Meric Koksal, Executive Vice-President and Head, CIBC Global Asset Management. "These awards reflect the deep expertise of our team, the strength of our partnerships and growing demand for our ETF and investment solutions."CIBC Globa

    $CM
  • QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director
    PR·

    QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director

    QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that shareholders overwhelmingly approved the appointment of Jonathan M. Pratt as a Managing Director and member of the QIAGEN Managing Board at an Extraordinary General Meeting of Shareholders. Jon Pratt joined QIAGEN as Chief Executive Officer on September 1, 2026. Following today’s shareholder approval, he joins Roland Sackers, Chief Financial Officer, on QIAGEN’s Managing Board. Shareholders also overwhelmingly approved the discharge of Thierry Bernard for his service as a member of the Managing Board through September 1, 2026, when he stepped down as Chief Executive Officer and a Managing Board member. About

    $QGEN
  • MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)
    PR·

    MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)

    Colorectal cancer: in a human liver-metastasis organoid model resistant to botensilimab and balstilimab alone, the addition of agenT-797 supported immune reprogramming and tumor-cell killing, reinforcing the rationale for an ongoing Phase 2 combination studySenolytic activity: agenT-797 and FAP-targeted MiNK-215 cleared senescent cells left behind after chemotherapy; cells linked to relapse and to fibrotic disease, and FAP targeting extended MiNK-215's killing into the tumor's supporting stromaPulmonary development: findings highlight immune mechanisms relevant to acute inflammation, cellular senescence and tissue remodeling, supporting further investigation in MiNK's randomized Phase 2 tria

    $INKT
  • THE HOME DEPOT CANADA ANNOUNCES 2026 INNOVATION AWARD WINNERS
    PR·

    THE HOME DEPOT CANADA ANNOUNCES 2026 INNOVATION AWARD WINNERS

    In every space in the home, award-winning products take the friction out of DIY and elevate home improvement projects for customersAnnual Recognition Program: The Home Depot Canada's 2026 Innovation Awards recognize standout products that elevate home renovations for DIY and Pro customers by making projects faster, easier, and more efficient. Winner: Halstead/Halstead Polished Vinyl Tile earned first place for introducing the market's first polished vinyl tile, pairing a premium finish with waterproof durability and fast, easy installation. Runners-Up: CGC – UltraLight PRO drywall (first runner-up) and RYOBI High Flow Electric Pressure Washer (second runner-up) were recognized for lightweight,

    $HD
  • Datavault Board of Directors Appoints Brett Moyer as Chief Executive Officer and President; Names Kimberly Briskey Chair of the Board
    PR·

    Datavault Board of Directors Appoints Brett Moyer as Chief Executive Officer and President; Names Kimberly Briskey Chair of the Board

    Teri Gallo named Chief Operating Officer, Stanley Mbugua named Chief Financial Officer, Sri Peruvemba named Vice Chair, and Christopher R. Hardt appointed Chair of the Audit Committee The Company will provide a business update and report third-quarter financial results on a date to be announced. Datavault AI Inc. ("Datavault" or the "Company") (NASDAQ:DVLT) today announced that its Board of Directors has appointed Brett Moyer as Chief Executive Officer and President, Kimberly Briskey as Chair of the Board, Sri Peruvemba as Vice Chair of the Board, Teri Gallo as Chief Operating Officer, Stanley Mbugua as Chief Financial Officer and Christopher R. Hardt as Chair of the Audit Committee, ef

    $DVLT
  • SunCar Technology Group Announces Share Repurchase Program
    PR·

    SunCar Technology Group Announces Share Repurchase Program

    SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ:SDA), a Cayman Islands exempted company, today announced that its board of directors has authorized a share repurchase program to buy back up to $10 million of its outstanding Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares"). This program reflects the Company's confidence in its long-term growth prospects. The share repurchase program is expected for the next three months. The Company intends to fund the repurchases through a combination of cash on hand and cash generated from operations. The Company may repurchase shares of its Class A Ordinary

    $SDA
  • SuperCom to Report Third Quarter 2026 Financial Results on November 12th, 2026
    PR·

    SuperCom to Report Third Quarter 2026 Financial Results on November 12th, 2026

    SuperCom (NASDAQ:SPCB), a global provider of secure solutions for the IoT, cybersecurity, and digital identity sectors, will hold a conference call on Thursday, November 12, 2026, at 10 a.m. Eastern time (7 a.m. Pacific time / 5 p.m. Israel time) to discuss its financial results for the third quarter ended September 30, 2026. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period. Conference Call Dial-In Information:Date: Thursday, November 12, 2026 Time: 10 a.m. Eastern time (7 a.m. Pacifi

    $SPCB
  • Caterpillar Group President of Construction Industries Rod Shurman to Participate in Fireside Chat Hosted by Chad Dillard of Bernstein
    PR·

    Caterpillar Group President of Construction Industries Rod Shurman to Participate in Fireside Chat Hosted by Chad Dillard of Bernstein

    Caterpillar Inc. (NYSE:CAT) Group President of Construction Industries Rod Shurman is expected to participate in a fireside chat hosted by Chad Dillard of Bernstein in North Carolina on Tuesday, Nov. 17, from 11:15 a.m. to noon ET. The discussion will provide updates on Construction Industries' growth initiatives, including Cat Compact™, the company's $1 billion investment to expand manufacturing capacity in North Carolina, Major Projects and more. A real-time video webcast will be available to the public. Participants should visit the website at least 15 minutes before the live event

    $CAT
  • XTEND AI Robotics, Inc. Receives $8.3 Million Defense Order for Systems in Asia-Pacific
    PR·

    XTEND AI Robotics, Inc. Receives $8.3 Million Defense Order for Systems in Asia-Pacific

    Order pairs unmanned systems with a first-year XOS software update package This order is in addition to the approximately $84 million AI Robotics backlog reported as of September 30, 2026. XTEND AI Robotics, Inc. (NYSE:XTND) ("XTEND" or the "Company"), a leader in software systems and Physical AI, today announced that its Asia-Pacific subsidiary, Performance Rotors Pte Ltd, has received a purchase order valued at approximately $8.3 million from a defense customer in the region. The order covers multiple unmanned aerial systems, with associated ground control stations and accessories, and includes a first-year software update package for every system. The order reflects XTEND’s operating

    $XTND
  • Terreno Realty Corporation Acquires Property in Hyattsville, MD for $23.1 Million
    PR·

    Terreno Realty Corporation Acquires Property in Hyattsville, MD for $23.1 Million

    Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, acquired an industrial property located in Hyattsville, Maryland on November 5, 2026 for a purchase price of approximately $23.1 million. The property consists of a 6.1-acre improved land parcel improved with a 36,000 square foot building providing 17 grade-level loading positions. The property is at 5000 Tuxedo Road, adjacent to Terreno Realty Corporation’s 5380 Tuxedo Road property and the intersection of U.S. Route 50 and the Baltimore-Washington Parkway less than one mile outside Washington, D.C. The property is 100% leased to one tenant and the estimated st

    $TRNO
  • iRhythm Holdings to Participate in Upcoming Investor Conferences
    PR·

    iRhythm Holdings to Participate in Upcoming Investor Conferences

    iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the following investor conferences. Jefferies Global Healthcare Conference in London on Thursday, November 19, 2026, at 11:00 a.m. GMT (3:00 a.m. PT)9th Annual Evercore Healthcare Conference on Tuesday, December 1, 2026, at 2:10 p.m. ET (11:10 a.m. PT)Citi’s 2026 Global Healthcare Conference on Wednesday, December 2, 2026, at 1:40 p.m. ET (10:40 a.m. PT) Interested parties may access live and archived webcasts of the presentations on the

    $IRTC
  • HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company’s Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer’s 41st Annual Meeting
    PR·

    HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company’s Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer’s 41st Annual Meeting

    HCW11-018b induces/promotes tertiary lymphoid structure formation inside tumors HCW11-018b converts immunological "cold" tumors into "hot" tumors HCW11-018b was generated using the Company’s non-Fc TRBC platform, combining elements that enhance T-cell activation and tumor infiltration while mitigating immunosuppression

    $HCWB
  • Leading Academic Medical Centers to Present New AI-ECG Research on Viz.ai’s Cardio Suite at AHA 2026
    PR·

    Leading Academic Medical Centers to Present New AI-ECG Research on Viz.ai’s Cardio Suite at AHA 2026

    Studies from Beth Israel Deaconess and the University of Colorado highlight how AI-ECG can help clinicians identify suspected cardiac disease from routine ECGs Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that two research abstracts evaluating its AI-powered electrocardiogram (AI-ECG) technology within the Viz Cardio Suite have been accepted for presentation at the Hypertrophic Cardiomyopathy Medical Society (HCMS) meeting, held in conjunction with the American Heart Association’s Scientific Sessions 2026 in Chicago. Both studies focus on Viz HCM, the suite’s AI-ECG algorithm for detecting hypertrophic cardiomyopathy (HCM), a freque

    $BMY
  • FOX CORPORATION COMPLETES ACQUISITION OF ROKU
    PR·

    FOX CORPORATION COMPLETES ACQUISITION OF ROKU

    FOX Is Now One of the Leading Streaming Businesses in the U.S., Inclusive of Roku, Tubi and FOX One Roku's Open Distribution Platform to Continue Serving More Than 100 Million Households Worldwide, with Access to Thousands of

    $FOX$FOXA$ROKU
  • Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
    PR·

    Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("ASR") with Goldman Sachs & Co. LLC ("Goldman Sachs"), to repurchase $270 million of Align’s common stock under Align’s $1.0 billion stock repurchase program that was approved by Align’s Board of Directors in April 2025."This $270 million accelerated stock repurchase fulfills the share repurchase commitment we announced in July and is

    $ALGN
  • Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
    PR·

    Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)

    INTASYL siRNA - Redefining the Treatment Paradigm for Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. - November 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that it will present clinical data from its Phase 1b clinical trial at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which will be held in Phoenix, Arizona from November 6-8, 2026."The growing body of clinical evidence suggests that PH-762 may offer patients and physicians a meaningful new treatmen

    $PHIO